Silver-Doped BaSrTiO3 Nanocomposite: Synthesis, Characterization, Antibacterial and Photocatalytic Activities.

In this research, strontium titanate (SrTiO3), barium titanate (BaTiO3), barium strontium titanate (BaSrTiO3), and Ag-doped BaSrTiO3 nanocomposites with different Ag contents were fabricated using the sol-gel chemical route. The prepared samples were characterized by several techniques including scanning electron microscopy (SEM), X-ray diffraction (XRD), energy-dispersive X-ray spectroscopy (EDS), differential reflectance spectroscopy (DRS), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FTIR), inductively coupled plasma spectroscopy (ICP), and Brunauer-Emmett-Teller (BET) measurement. The EDS results indicated that the synthesized nanoparticles had a cube perovskite-like structure. The EDS and ICP results revealed that Ag was doped into the Ba0.5Sr0.5TiO3 structure. The SEM and TEM images demonstrated that the particle size of 15 mol% Ag-doped Ba0.5Sr0.5TiO3 was smaller than that of pure Ba0.5Sr0.5TiO3 as confirmed by surface area results. The photocatalytic properties of undoped titanate samples and Ag-doped Ba0.5Sr0.5TiO3 were studied by the photodecomposition of Eosin yellowish (EY) and methylene blue (MB) dyes. The results illustrated that the photodegradation efficiency of the Ag-doped Ba0.5Sr0.5TiO3 was far higher than the undoped titanate sample, and the optimum Ag doping was 15 mol%. The antibacterial activities of pure Ba0.5Sr0.5TiO3 and Ag-doped Ba0.5Sr0.5Ti03 were studied against Staphylococcus aureus as Gram-positive (+) and Pseudomonas aeruginosa and Escherichia coli as Gram-negative (-) bacteria. In comparison with the bare Ba0.5Sr0.5TiO3 nanoparticles, the Ag-doped sample showed a significant enhancement in antibacterial activities against both Gram-negative and Gram-positive bacterial strains.

The relationship between iron bone marrow stores and response to treatment in pediatric acute lymphoblastic leukemia.

Iron is an intracellular element whose accumulation in the body is associated with tissue damage. This study examines the effect of iron on pediatric acute lymphoblastic leukemia (ALL) and its "response to treatment." At the end of the first year of treatment, bone marrow iron store (BMIS) was evaluated in children with ALL and the relationship between iron store and minimal residual disease was investigated. Moreover, the 3-year disease-free survival (3-DFS) of patients was determined. Patients' BMIS were compared with that of subjects with normal bone marrow. The study examined 93 children, including 78 Pre-B and 15 T-cell ALL patients. BMIS did not differ between the children with ALL and those with no evidence of cancer. BMIS was increased in 26.6% of patients at the end of the first year of treatment. Drug resistance and BM relapses were more prevalent in cases with high BMIS in both Pre-B and T-cell groups. Bone marrow iron store is not considered a risk factor for childhood ALL. However, high levels of BMIS are associated with poor response to treatment and the risk of relapse. Bone marrow iron store control during treatment can therefore help achieve better outcomes and improve the chances of recovery.

The pros and cons of the fourth revision of thalassaemia screening programme in Iran.

Objective To evaluate the repercussions of recent changes to the cut-offs used in the first screening step of the pre-marital screening programme for thalassaemia prevention in Iran. Methods The profiles of 984 subjects referred to a genetic laboratory, and the tests of 242 parents of children with thalassaemia major were assessed for red blood cell (RBC) indices, haemoglobin (Hb) A2 levels and results of Hb electrophoresis. Results Of 407 suspected thalassaemia minor (STM) cases, 18 proved positive for thalassaemia minor on molecular analysis (18/407, confidence interval 2.6-6.9%). If the revised screening cut-offs had been used to determine who would undergo molecular analysis, two of these cases would not have been identified. Only 4.4% of suspected cases with lower than normal RBC indices (mean corpuscular volume <80 fl and mean corpuscular Hb <27 pg) and HbA2 (<3.5%) were diagnosed with thalassaemia minor. Conclusion The thalassaemia major prevention programme is performed in two separate steps. One step involves the screening of subjects and identification of ß-thalassaemia minor, suspected cases for thalassaemia minor (STM), and normal subject groups. The other step concerns the identification of thalassaemia minor in the STM group. Changing the cut-offs at the first screening step does not result in significant improvement from an economic view, and is associated with significant risk at the second screening step.

Application of nanostructured drug delivery systems in immunotherapy of cancer: a review.

The cancer immunotherapy method uses the specificity of the immune system to provide a more effective than more conventional treatments, such as chemotherapy and radiotherapy. Immunotherapy has two main strategies (passive or active) to organize the immune system. Passive strategies use advantage of tumor-hyperpermeable cells, which have enhanced permeability and retention effects. Nanoparticles due to their better accumulation within tissues and cells of the immune system are well suitable for delivery of immune therapies such as vaccines or adjuvants. In this review, we explained application of nanotechnology in immunotherapy of cancer.

Preparation, Surface Properties, and Therapeutic Applications of Gold Nanoparticles in Biomedicine.

Gold nanoparticles (AuNPs) due to their unique properties and manifold surface functionalities have been applied in bio-nanotechnology. The application of GNPs in recent medical and biological research is very extensive. Especially it involves applications such as detection and photothermalysis of microorganisms and cancer stem cells, biosensors; optical bio-imaging and observing of cells and these nanostructures also serve as practical platforms for therapeutic agents. In this review we studied all therapeutic applications of gold nanoparticles in biomedicine, synthesis methods, and surface properties.

Lanthanum and zirconium co-doped ZnO nanocomposites: synthesis, characterization and study of photocatalytic activity.

Nanocomposits of zinc oxide co-doped with lanthanum and zirconium were prepared using the modified sol-gel method. The samples were characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), energy dispersive spectroscopy (EDS), diffuse reflectance spectroscopy (DRS), and BET surface area measurement. For comparison, the La and Zr mono doped ZnO have also been prepared under the same conditions. The XRD results revealed that all the materials showed a hexagonal wurtzite crystal structure. It was found that the particle size of La-Zr-doped ZnO is much smaller as compared to that of pure ZnO. The effect of operational parameters such as, doping concentration, catalyst loading, pH and initial concentration of methylene blue on the extent of degradation was investigated. The photocatalytic activity of the undoped ZnO, mono-doped and La-Zr-ZnO photocatalysts was evaluated by the photocatalytic degradation of methylene blue in aqueous solution. The presence of lanthanium and/or zirconium causes a red shift in the absorption band of ZnO. The results show that the photocatalytic activity of the La-Zr-ZnO photocatalyst is much higher than that of undoped and mono-doped ZnO, resulting from the La and Zr synergistic effect. The co-operation of the lanthanum and zirconium ion leads to the narrowing of the band gap and greatly improves the photocatalytic activity. The photocatalyst co-doped with lanthanum and zirconium 4 mol% shows the best photoactivity and photodecomposition efficiencies were improved by 92% under UV-Vis irradiation at the end of 30 min, compared with the pure and mono doped samples.